An Adult with Blisters and Milia on Trauma-Prone Sites

[1]  D. Zillikens,et al.  Epidermolysis bullosa acquisita: What’s new? , 2010, The Journal of dermatology.

[2]  K. Harman,et al.  A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high‐titre epidermolysis bullosa acquisita , 2007, The British journal of dermatology.

[3]  Mei Chen,et al.  Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. , 2005, The Journal of investigative dermatology.

[4]  H. Nakagawa,et al.  A Case of Nonscarring Subepidermal Blistering Disease Associated with Autoantibodies Reactive with Both Type VII Collagen and Laminin 5 , 2003, Dermatology.

[5]  J. R. McMillan,et al.  Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa , 2003, Experimental dermatology.

[6]  D. West,et al.  The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. , 2002, Archives of dermatology.

[7]  A. Ahmed,et al.  Emerging treatment for epidermolysis bullosa acquisita. , 2001, Journal of the American Academy of Dermatology.

[8]  K. Yancey,et al.  Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. , 2000, Archives of dermatology.

[9]  B. Solomon,et al.  Mucosal morbidity in patients with epidermolysis bullosa acquisita. , 1999, Archives of dermatology.

[10]  T. Hashimoto,et al.  Epidermolysis bullosa acquisita associated with epidermal‐binding circulating antibodies , 1997, The British journal of dermatology.

[11]  H. Shimizu,et al.  Epidermolysis bullosa acquisita: report of a case with comparison of immunogold electron microscopy using pre‐ and postembedding labelling , 1996, The British journal of dermatology.

[12]  P. Santoianni,et al.  Drug-induced cutaneous porphyria. , 1993, Clinical Dermatology.

[13]  R. Briggaman,et al.  Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. , 1993, Dermatologic clinics.

[14]  E. Mooney,et al.  Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. , 1990, The Journal of investigative dermatology.

[15]  D. Woodley,et al.  Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. , 1988, The Journal of investigative dermatology.

[16]  D. Woodley,et al.  Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. , 1984, The New England journal of medicine.

[17]  R. Briggaman,et al.  Epidermolysis bullosa acquisita: ultrastructural and immunological studies. , 1981, The Journal of investigative dermatology.

[18]  S. C. Kim,et al.  Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. , 1996, Dermatology.